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A B S T R A C T
Bacterial spores displaying heterologous proteins have been proposed as a safe and eﬃcient method for delivery
of antigens and enzymes to animal mucosal surfaces. Initial studies have been performed using Bacillus subtilis
spores, but other spore forming organisms have also been considered. B. megaterium spores have been shown
capable of displaying large amounts of a model heterologous protein (Discosoma red ﬂuorescent protein mRFP)
that in part crossed the exosporium to localize in the space between the outer coat layer and the exosporium.
Here, B. megaterium spores have been used to adsorb Bcp1 (bacterioferritin comigratory protein 1), a peroxir-
edoxin of the archaeon Sulfolobus solfataricus, known to have an antioxidant activity. The spores were highly
eﬃcient in adsorbing the heterologous enzyme which, once adsorbed, retained its activity. The adsorbed Bcp1
localized beneath the exosporium, ﬁlling the space between the outer coat and the exosporium. This unusual
localization contributed to the stability of the enzyme-spore interaction and to the protection of the adsorbed
enzyme in simulated intestinal or gastric conditions.
Introduction
The delivery of drugs and antigens by the oral or nasal routes oﬀers
several advantages over parenteral administration and is gaining in-
creasing relevance for the treatment of human and animal diseases.
Mucosal routes are promising alternatives to delivery by injection, be-
cause the high vascularization of the mucosal surfaces allows the direct
transfer of molecules into the systemic circulation [1]. However, the
number of drugs and antigens that can be eﬀectively administered by
the oral or nasal route is severely limited by the rapid loss of activity
encountered by many of these molecules at mucosal sites. Therefore,
the successful development of mucosal therapeutic molecules relies on
eﬃcient delivery systems, able to stabilize and protect the molecules
from degradation and to reduce or avoid completely the loss of biolo-
gical activity [2]. A variety of drug delivery systems has been proposed,
including live microorganisms, virus particles, synthetic nanoparticles,
liposomes, microspheres, gels and cyclodextrins [2,3]. Bacterial spores
displaying heterologous proteins have also been proposed as a tool for
the delivery of molecules to mucosal surfaces [4,5]. Spores are
extremely stable and are potentially able to combine some advantages
of live microrganisms with those of synthetic nanoparticles [4,5].
Bacterial spores are mainly formed by Gram-positive organisms of
diﬀerent genera and including more than 1000 species [6] in response
to harsh environments. Spores can survive in a dormant state for long
periods, resisting stresses such as high temperature, dehydration, ab-
sence of nutrients, and presence of toxic chemicals. Their use as a drug/
antigen delivery system has been fostered by their high stability [7] and
by the safety record of several species of spore formers [8]. Initially,
spores of the model organism Bacillus subtilis were used [9], but other
Bacillus species have also been tested for the display and mucosal de-
livery of antigens and enzymes [4,10].
Here, the use of spores of B. megaterium for the delivery of ther-
apeutic molecules to the gastrointestinal mucosa is proposed. The B.
megaterium spore is particularly promising as a delivery vehicle due to
its large dimensions (length up to 3 μm and diameter of 1 μm, with a
spore surface area about 2.5-fold larger than that of B. subtilis) [11] and
the presence of an exosporium, a protective layer surrounding the spore
found only in some spore-forming species [12,13]. The exosporium of
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spores of QM B1551, the best-characterized strain of B. megaterium,
have recently been shown to be essential for the adsorption of the red
ﬂuorescent protein of the coral Discosoma sp (mRFP) [14]. mRFP was
shown to cross the exosporium and localize in the inter-coat space [14].
We used a well-characterized archaeal enzyme, the bacterioferritin
comigratory protein 1 (Bcp1) of Sulfolobus solfataricus, belonging to
peroxiredoxin family [15–19], as a model to study the spore-based
delivery of therapeutic agents to mucosal surfaces. Peroxiredoxins are
thiol peroxidases commonly found in archaea and eukaryotes, including
humans, and known to contribute to cell protection against inorganic
and organic peroxides [18]. Recently, the highly thermostable Bcp1 of
S. solfataricus has been found to protect cardiomyoblasts from oxidative
stress in vitro and was proposed as potentially a health beneﬁcial mo-
lecule with anti-oxidant activity [20]. The delivery of enzymes with
antioxidant activity, such as Bcp1, may be a new strategy to address
inﬂammation caused by oxidative stress [21,22].
Materials and methods
Materials and suppliers
Difco Sporulation medium (DSM) - Oxoid, UK, 234000; BRAND®
counting chamber BLAUBRAND® Bürker-Türk-Sigma, USA, BR719505;
Isopropyl-β-D-thiogalactoside (IPTG) - Sigma, USA,6758;
Ethylenediaminetetraacetic acid (EDTA) - Sigma, USA, E9884; Protran
0.45 NC nitrocellulose Western blotting membranes - Amersham
Pharmacia Biotech, 10600002; His Trap HP – GE Healthcare, USA, 11-
0012-38 AH; DL-Dithiothreitol (DTT) - Sigma, USA, D0632; Anti-poly-
histidine-horseradish peroxidase coupled antibody - Sigma, USA,
A7058; Bovine serum albumin (BSA) - Sigma, USA, A2153
Bacterial strains and spore puriﬁcation
B. megaterium strains QM B1551 and PV361 [13] and B. subtilis
strain PY79 [23] were used. Sporulation was induced by the exhaustion
method [8]. After 30 h growth in Difco Sporulation medium (DSM) at
37 °C with vigorous shaking, spores were collected, washed 3 times
with distilled water and incubated overnight in distilled water at 4 °C to
lyse residual sporangial cells as previously described [14]. Spore counts
were determined by direct counting with a Bürker chamber [Sigma,
USA (BR719505)] under an optical microscope (Olympus BH-2 with
40× lens).
Expression and puriﬁcation of Bcp1
BL21 Escherichia coli strain expressing Bcp1 protein [16] was grown
to 0.8 OD600nm in Luria-Bertani (LB) medium supplemented with ka-
namycin (10 μgmL-1) and chloramphenicol (34 μgmL-1) at 37 °C. Ex-
pression was induced by 1mM isopropyl-β-D-thiogalactoside (IPTG)
[Sigma, USA (6758)] for 6 h at 37 °C as previously described [16,24].
The cells were harvested by centrifugation, resuspended in 20mM Tris-
HCl pH 8.0 containing a complete EDTA [Sigma, USA (E9884)] free
Fig. 1. Adsorption of Bcp1 to B. megaterium spores.
5× 108 spores of QM B1551 and PV361 strains were incubated with 20, 50 or
70 μg of Bcp1 and then the samples subject to centrifugation. (A) Spore surface
proteins were extracted from the pellet fractions by SDS-DTT treatment, separated
by SDS-PAGE and analyzed by western blot with an anti-polyhistidine antibody
conjugated to horseradish peroxidase. Free Bcp1 (Bcp1) was used as a marker and
free spore protein extracts as control (-). Whole images of western blots are re-
ported in the Supplementary material. (B) The percentage of spore-adsorbed Bcp1
was calculated from dot blotting (Figs. 1 and 2) of the supernatants fractions
containing unbound Bcp1, and relative densitometric analysis (Supplementary
material, Additional Table 1–2). (C) Peroxidase activity of QM B1551 spores (grey
bars), of 20 and 50 μg of free Bcp1 (white bars) or of the same amounts of enzyme
adsorbed to spores (black bars). Error bars show the standard errors of the mean
from the three diﬀerent experiments. P value< 0.05.
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protease inhibitors cocktail and disrupted by ultrasonication with
20min pulses at 20 Hz (Sonicator Ultrasonic liquid processor; Heat
System Ultrasonics Inc.).
Protein puriﬁcation was carried out in two steps: heat treatment of
the cell extract at 80 °C for 15min and aﬃnity chromatography by His
Trap HP [19]. The suspension was clariﬁed by ultracentrifugation at
160,000 x g for 30min. The crude extract obtained was heated at 80 °C
for 15min, and then centrifugated at 15,000 x g at 4 °C for 30min re-
moving almost 70% of the mesophilic host proteins. The extract was
concentrated (Amicon, Millipore Corp.; Bedford, MA, USA) and applied
to a HisTrap HP [GE Healthcare, USA (1-0012-38 AH)] equilibrated
with 50mM Tris/HCl, pH 8.0, 0.3M NaCl (buﬀer A). The column was
washed with buﬀer A with 20mM imidazole, and proteins were eluted
with buﬀer A supplemented with 250mM imidazole. The active frac-
tions were pooled and dialyzed against 20mM Tris/HCl, pH 8.0. [16].
Adsorption reaction
Diﬀerent amounts of puriﬁed Bcp1 were incubated with 5× 108
spores in 200 μl of 50mM sodium citrate pH 4.0 at 25 °C [25,26]. After
1 h incubation, the binding mixture was centrifuged (10min at
13,000xg at room temperature) to separate Bcp1-adsorbed- spores in
the pellet from free Bcp1 in the supernatant [25,26].
Western blot and dot-blot analysis
Extraction of proteins from spores and Bcp1-adsorbed spores was
performed by treatment at 65 °C in 40 μl of sodium dodecyl sulfate
(SDS)-dithiothreitol (DTT) extraction buﬀer [10mM tris pH 8.0, 1%
SDS, 50mM DTT, 10mM EDTA, 50mM Tris−HCl, pH 8.0]. 20 μl of
extracted proteins were separated on 12.5% denaturing poly- acryla-
mide gels, electrotransferred to nitrocellulose membranes [Amersham
Fig. 2. Immunoﬂuorescence microscopy of B. megaterium spores adsorbed with increasing amounts of puriﬁed Bcp1. (A) After adsorption reaction with
diﬀerent amount of Bcp1 (10, 20, 30, or 50 μg) of Bcp1, QMB 1551 and PV361 spores were reacted with mouse anti-polyhistidine primary antibody and ﬂuorescein
isothiocyanate-conjugated secondary anti-mouse IgG. The same microscopy ﬁeld for phase contrast (PC) and immunoﬂuorescence (IF) is shown together with the
merge panel. The exposure time was 500ms for all images. Scalebar,1 μm. (B) Data are expressed as ﬂuorescence intensity in arbitrary unit (a.u.) and represent the
mean of ﬁfty spores in each group. P value< 0.01.
Fig. 3. Kinetics of Bcp1 release. Bcp1-adsorbed spores were incubated either in
0.1M glycine−HCl, pH 2.0 (triangles), 0.1 M citrate-phosphate pH 6.0 (circle) or
0.1M HEPES pH 7.0 (diamonds) and the amount of released Bcp1 estimated by
dot blot assay and its relative densitometric analysis (Supplementary material,
Additional Fig. 3).
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Pharmacia Biotech, (10600002)] and analysed by western blot using a
monoclonal anti-polyhistidine-horseradish peroxidase coupled anti-
body (1:7000) [Sigma, USA (A7058)], as previously reported [26]. A
quantitative determination of the amount of Bcp1 was obtained by dot
blot experiments comparing serial dilutions of puriﬁed Bcp1 and
binding assay supernatant. Filters were then visualized by the ECL-
substrates method (Clarity, Bio-rad) and subjected to densitometric
analysis by Quantity One 1-D Analysis Software (Bio-Rad) [26]. Dot
blot and relative densitometric analyses were performed 3 times.
Fluorescence and immunoﬂuorescence microscopy
Immunoﬂuorescence experiments were performed as described
[14]. 2.0× 106 Bcp1-adsorbed spores of QM B1551 and PV361 were
incubated with 1% bovine serum albumin (BSA) ([Sigma, USA
(A7058)] for 30min and then for 2 h with mouse monoclonal anti-
polyhistidine antibodies (1:200) in 1xPBS-1% BSA. Samples were wa-
shed and treated with a 1:64 goat anti-mouse IgG secondary antibody
conjugated with ﬂuorescein isothiocyanate, FITC [Thermo Fisher Sci-
entiﬁc, USA (62-6511)] (1 h at 4 °C, in the dark). After 4 washes, the
samples were resuspended in 20 μl of 1xPBS and 10 μl were analyzed.
For the analysis of mRFP-adsorbed spores, following the adsorption
reaction the spores were resuspended in 50 μl of 1xPBS pH 4.0 and 5 μl
of the suspension observed by ﬂuorescence microscopy [27].
All samples were observed with an Olympus BX51- DP70 ﬂuores-
cence microscope ﬁtted with a 100x UPlan F1 oil objective; U-MNG or
U-MWIBBP cube-ﬁlters were used to detect the red ﬂuorescence emis-
sion of mRFP or the green emission of FITC-conjugated antibodies
respectively. ImageJ (v1.48, NIH) was used to draw an outline around
50 spores for each strain and mean ﬂuorescence values per pixel were
recorded for each spore [14,27].
Peroxidase activity
The peroxidase activity of free or spore-adsorbed Bcp1 was tested as
previously reported [28]. 100 μl of reaction mixture (50mM HEPES pH
7.0, 10mM DTT 0.2 mM H2O2) containing diﬀerent concentrations of
Bcp1, spores or Bcp1-adsorbed spores were incubated at 37 °C for 5min.
900 μl of trichloroacetic acid (10%, w/v) were added to stop the reac-
tions and the mixture was combined with 200 μl of 10mM ferrous
ammonium sulfate Fe(NH4)2(SO4)2 and 100 μl of 2.5M potassium
thiocyanate KSCN, which led to the formation of a red colored iron
complex. The peroxide concentration is proportional to the color in-
tensity measured at λ=492 nm [28]. The percentage of peroxide re-
moved was calculated on the basis of the change in A492nm obtained
with Bcp1 relative to that obtained without Bcp1 [28].
Treatments with simulated gastric and intestinal ﬂuids
Free Bcp1, spores and Bcp1-adsorbed spores were incubated for 1 h
at 37° in 100 μl of simulated gastric juice (SGF) [1mg of pepsin (porcine
stomach mucosa; Sigma) per ml of 10mM HCl; pH 2.0] or small in-
testine ﬂuid (SIF) [1mg of pancreatin (porcine pancreas; Sigma) per ml
and 0.2% bile salts (50% sodium cholate-50% sodium deoxycholate;
Sigma); pH 6.8]. To remove the proteases contained in SIF and SGF,
after incubation, the samples containing free Bcp1 were treated at 90 °C
Fig. 4. Displacement assays.
(A) Peroxidase activity of 5.0×108 spores of QMB 1551 alone (light grey bar) or adsorbed with 50 μg of Bcp1 (Bcp1 - dark grey bar) and then with mRFP
(Bcp1+RFP - black bars)., The assay was performed after 1, 1.5 and 2 h from the addition of mRFP. (B) QM B1551 spores were adsorbed with 5 μg of mRFP (RFP) or
with 50 μg of Bcp1 and then with 50 μg of mRFP (RFP+Bcp1), washed and analyzed by ﬂuorescence microscopy after 1 or 2 h of incubation. The livery of enzymes
with antioxidant activity, such as Bcp1, may be a same ﬁeld was observed by phase contrast and ﬂuorescence microscopy. The merge panel is shown. The exposure
time was 200ms. Scalebar,1 μm. (C) Peroxidase activity of QMB 1551 spores (light grey bar) or adsorbed with 50 g of mRFP (RFP - dark grey bar) and then with 50 g
of Bcp1 (RFP+Bcp1 - black bars); the experiment was performed as described in (A).
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for 15min while samples containing spores were centrifuged for 10min
at 13000xg [29].
For the pH-stability assay, free Bcp1, spores and Bcp1-adsorbed
spores were incubated at 37 °C for 1 h in following buﬀers: 0.1M gly-
cine-HCl pH 2.0; 0.1M citrate-phosphate pH 4.0 and pH 6.0, or 0.1 M
HEPES pH 7.0. After incubation, the peroxidase activity of the samples
was measured following the protocol described above [16].
Statistical analysis
Results of peroxidase activity analysis are the means of 3 in-
dependent experiments. The error bars reported in the ﬁgures show the
standard errors of the mean from the 3 experiments. Statistical sig-
niﬁcance was determined by Student t-test, using Microsoft Oﬃce
Excel, and the signiﬁcance level was set at P < 0.05.
Results and discussion
Display of active Bcp1 of S. solfataricus on B. megaterium spores
To verify whether B. megaterium spores were able to adsorb Bcp1
onto their surface, 20, 50 or 70 μg of the puriﬁed enzyme was incubated
with 5.0× 108 puriﬁed spores of QM B1551 or PV361. The reactions
were performed in 50mM sodium citrate at pH 4.0 [25]. After the re-
action, spores were extensively washed with PBS pH 4.0, collected by
centrifugation, surface proteins extracted and analyzed by western
blotting. As shown in Fig. 1A, speciﬁc signals were observed with ex-
tracts of spores reacted with the diﬀerent amounts of puriﬁed Bcp1,
indicating that Bcp1 was absorbed during the reaction by spores of both
strains and released by the extraction treatment.
Bcp1 was apparently extracted in comparable amounts from spores
of QM B1551 previously adsorbed with 50 and 70 μg of the enzyme. To
conﬁrm this observation, a well-established procedure [9,14,26,27]
was followed and the amount of Bcp1 remaining unbound was
quantiﬁed, i.e., post-adsorption spores were collected by centrifugation
and the supernatant serially diluted and analyzed by dot blotting
(Supplementary material, Additional Figs. 1 and 2). The results of the
densitometric analysis (Supplementary material, Additional Tables 1
and 2) are shown in Fig. 1B and indicated that with QMB 1551 spores,
almost all the Bcp1 was adsorbed when using 20 or 50 μg in the reaction
(100 and 95% respectively). The eﬃciency of adsorption decreased by
about 40% when 70 μg of enzyme was used, suggesting saturation of
the adsorption with 50 μg (Fig. 1B). With PV361 spores, the eﬃciency
of adsorption was lower than with QMB 1551 at all concentrations of
Bcp1. With the lowest Bcp1 concentration analyzed (20 μg), only 60%
of the enzyme was adsorbed and a maximum of about 30 μg of adsorbed
Bcp1 was observed when 50 or 70 μg was used in the reaction (Fig. 1B).
Based on these results, it was concluded that 5.0× 108 spores of QMB
1551 are able to adsorb about 50 μg and that the exosporium, present in
QM B1551 and absent in PV361, is essential for an eﬃcient adsorption
of Bcp1.
To assess whether spore-adsorbed Bcp1 retained its enzymatic ac-
tivity the eﬃciency of H2O2 removal by the free and spore-bound en-
zyme was assayed. As a control, B. megaterium QM B1551 and PV361
spores alone were assayed and showed an antioxidant activity (white
bars in Fig. 1C). Interestingly, PV361 spores were less eﬃcient than QM
B1551 in removing H2O2, suggesting that antioxidant activity was lo-
calized in the exosporium. Although we cannot distinguish between the
enzymatic activity due to the adsorbed Bcp1 or to the spore itself, QM
B1551 spores adsorbed with Bcp1 had an antioxidant activity higher
than similar amounts of free Bcp1 and also than spores alone, indicating
that the adsorbed enzyme was active (grey bars in Fig. 1C). With Bcp1-
adsorbed PV361 spores, the antioxidant activity was lower than the free
enzyme but higher than that of spores alone, suggesting that the small
amount of enzyme adsorbed to spores (Fig. 1B) was active (Fig. 1C).
Thus, the activity observed with Bcp1 adsorbed to spores is most likely
due to the combination of the activities of the adsorbed enzyme and of
the spores, with QM B1551 spores being more eﬃcient that PV361 in
Fig. 5. Eﬀect of SIF and SGF on spore adsorption. (A) Western blotting, performed with Bcp1-recognizing anti-polyhistidine antibody, of free Bcp1 and of proteins
extracted from spores of B. megaterium QM B1551 and PV361 adsorbed with 30 μg and 50 μg of Bcp1 respectively. Free and spore-adsorbed enzyme was not treated
(UnT) or treated with SIF or SGF (see Methods). Whole images of western blots are reported in the Supplementary material. (B) Peroxidase activity of 5.0× 108
spores of QM B1551 (white bars), of 50 μg of free Bcp1 (black bars) or of the same amount of enzyme adsorbed to spores (grey bars) without (UnT) or with SIF or SGF
treatment. (C) The experiment was performed as described in (B), but using 20 μg of enzyme. Error bars show the standard errors of the mean of three independent
experiments (P < 0.05).
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adsorbing active Bcp1.
Bcp1 localizes in the inter-coat space
Immunoﬂuorescence was used to localize the adsorbed Bcp1 on the
spore surface. 5.0× 108 spores of strains QM B1551 or PV361 after
adsorption of various amounts of Bcp1, were reacted with Bcp1-re-
cognizing anti-polyhistidine antibody and a ﬂuorescent secondary anti-
mouse IgG. As shown in Fig. 2A, with QMB 1551 spores almost no
ﬂuorescence was observed when 10 μg of Bcp1 was used and only a
weak ﬂuorescence signal, localized in spots, was observed with 20 μg of
enzyme. Stronger signals were observed by increasing the amount of
Bcp1 to 30 and 50 μg; however, with 30 μg the signal appeared non-
uniform but rather comprised of spots interrupted by non-ﬂuorescent
regions (Fig. 2A). With PV361 spores, the ﬂuorescent signal was almost
absent with 10 μg of enzyme but present and evenly distributed around
the spores with all other concentration of Bcp1 (Fig. 2A).
The ﬂuorescent signal intensity was quantiﬁed using ImageJ soft-
ware [11]. The mean value determined was higher with PV361 than
with QMB 1551 spores when 10 or 20 μg Bcp1 were used (Fig. 2B). The
signals were of similar intensity when spores of the two strains were
reacted with 30 μg and became stronger with QM B1551 than PV361
when 50 μg of enzyme were used (Fig. 2B). These results are not con-
sistent with the previous results (Fig. 1) showing that QM B1551 were
more eﬃcient than PV361 spores in absorbing Bcp1.
To explain this apparent inconsistency, we hypothesized that, with
QM B1551 spores, the enzyme was unavailable to the Bcp1-detecting
antibody because the Bcp1 had crossed the exosporium and localized in
the inter-coat space, as previously reported for the mRFP protein [11].
According to this, when 10 or 20 μg of Bcp1 were used for the ad-
sorption reaction all Bcp1 crossed the exosporium of QMB 1551 spores,
localizing in the inter-coat space and becoming mostly unavailable to
antibody. By increasing the amount of Bcp1 in the adsorption reaction,
the inter-coat space was gradually ﬁlled up and with 30 and 50 μg of
enzyme strong but still irregular signals were observed (Fig. 2A). With
spores lacking the exosporium (PV361) all Bcp1 adsorbed to spores was
recognized by antibody, producing a strong and uniformly distributed
signal.
Bcp1 is stably and tightly adsorbed to QM B1551 spores
To test the stability of Bcp1 adsorption, adsorbed spores were in-
cubated at 37 °C under various conditions of pH. After 30 and 60min,
spores were collected by centrifugation and the amount of Bcp1 present
in the supernatant measured by dot-blotting (Supplementary material,
Additional Fig. 3). Fig. 3 shows the results of the densitometric analysis
of the dot-blot (Supplementary material, Additional Table 3) and in-
dicated that at pH 4.0 no Bcp1 was found in the supernatants, while at
pH 6 and 7 some of the adsorbed enzyme was released. The release of a
maximum of 20% of Bcp1 after 1 h at pH 7.0 was unsurprising, as it was
already known that the adsorption of several other proteins to spores of
B. subtilis or B. megaterium preferentially occurred at pH 4.0 and was
less eﬃcient at other pHs [13,26,27].
To further analyze the stability of the interaction between Bcp1 and
QM B1551 spores a displacement assay was performed using Discosoma
red ﬂuorescent protein mRFP, already shown to eﬃciently adsorb onto
QM B1551 spores [14]. 5× 108 spores were reacted with 50 μg of Bcp1,
washed and then incubated with 50 μg of mRFP. After 1, 1.5 and 2 h
incubation, the antioxidant activity of spores was measured. As shown
in Fig. 4A, antioxidant activity measured in the absence of mRFP (dark
grey bar) was only slightly reduced by incubation with the competing
protein (black bars), suggesting that the adsorbed Bcp1 was not dis-
placed by mRFP. Spores adsorbed with Bcp1 and then with mRFP were
also analyzed by ﬂuorescence microscopy. As shown in Fig. 4B, the red
ﬂuorescence signal was weak compared to spores adsorbed only with
mRFP and did not increase over time, conﬁrming that mRFP was not
able to replace the previously adsorbed Bcp1. In a parallel experiment,
spores were reacted with mRFP and then with Bcp1. Consistently, the
antioxidant activity of spores was only minimally increased by the
adsorption of Bcp1 (Fig. 4C, black bars), indicating that Bcp1 was also
unable to displace mRFP. The results indicate that the adsorption of
heterologous proteins to spores is tight and cannot be displaced by a
second heterologous protein present in high concentration outside the
spore.
Eﬀects of simulated gastric or intestinal conditions on Bcp1-adsorbed spores
To analyze the eﬀects of simulated intestinal conditions on Bcp1
adsorbed onto spores, Bcp1-adsorbed spores of the QMB 1551 and
PV361 strains were treated with simulated gastric ﬂuid (SGF) or si-
mulated intestinal ﬂuid (SIF). Since spores of the two strains adsorb
Bcp1 with diﬀerent eﬃciencies (Fig. 1), in order to have similar
amounts of enzyme adsorbed to spores of the two strains, 5.0× 108
spores of the QMB 1551 and PV361 strains were adsorbed with 30 μg
and 50 μg respectively. After the adsorption reaction, spores were
treated with SGF or SIF, washed, and used to extract surface proteins
which were analyzed by western blotting as above. In parallel, the same
amount of free Bcp1 was also treated with SGF or SIF and analyzed by
western blot. As shown in Fig. 5A, free Bcp1 was totally degraded by
SGF treatment and only a minimal amount of the enzyme was still
detected after the SIF treatment. Bcp1 adsorbed to PV361 spores,
lacking the exosporium, was totally degraded by both SGF or SIF
treatments. Bcp1 molecules were, in contrast, still extractable and de-
tected after either treatment when adsorbed on QMB1551 spores, in-
dicating that they were only partially aﬀected by SGF or SIF (Fig. 5A).
To verify whether the enzyme activity was still present on QMB
1551 spores after the SIF or SGF treatment, their antioxidant activity
was analyzed. As shown in Fig. 5B, the antioxidant activity of the spores
alone was not aﬀected by either treatment (white bars), while the ac-
tivity of the free enzyme (50 μg) was strongly aﬀected by both (black
bars). The activity of 5.0× 108 spores adsorbed with 50 μg of Bcp1 was
also aﬀected, but the reduction was about 20% and 30% with SIF and
SGF respectively (Fig. 5B). Both SGF and SIF aﬀected free and spore-
bound Bcp1, but the antioxidant activity of spore-bound Bcp1 was
slightly higher than the sum of the activities of spores and free enzyme
(Fig. 5B), suggesting that at least part of the adsorbed enzyme was still
active after the treatments. Partial protection from degradation of the
adsorbed Bcp1 is not surprising, since it has been previously reported
that the β-galactosidase of Alicyclobacillus acidocaldarius was protected
against heat and acidic conditions when adsorbed on B. subtilis spores
[25].
For Bcp1, protection was only observed with QM B1551 spores and
not with PV361 (Fig. 5A), indicating that the exosporium is essential for
this eﬀect. A possible explanation for the partial protection of Bcp1 on
QM B1551 is that the enzyme, localized in the inter-coat space (Fig. 2),
was protected by the exosporium and was not accessible to degradative
enzymes. We hypothesized that these proteases were not able to cross
the exosporium and degrade Bcp1 because, as shown for mRFP (Fig. 4),
the inter-coat space was already fully occupied by Bcp1. For veriﬁca-
tion, the experiment of Fig. 5B was repeated, adsorbing QM B1551
spores with a reduced amount of enzyme (20 μg), insuﬃcient to com-
pletely ﬁll the inter-coat space. As shown in Fig. 5C, the activity of
spores adsorbed with 20 μg of Bcp1 was strongly reduced by SIF and
almost completely eliminated by the SGF. The antioxidant activity of
spore-bound Bcp1 was slightly higher than or identical to that of spores
alone after the SIF or SGF treatment, respectively (Fig. 5C), indicating
that the enzyme was almost completely degraded. Thus, under these
conditions, some of the protease contained in SGF and SIF apparently
crossed the exosporium and degraded Bcp1, supporting the hypothesis
that the protection of Bcp1 observed in Fig. 5A, B was due to the in-
ability of the degradative molecules to enter the pre-ﬁlled inter-coat
space.
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Conclusions
The main conclusion of this report is that the thermoacidophilic
enzyme Bcp1 of S. solfataricus can be eﬃciently adsorbed nto spores of
B. megaterium, with about 50 μg adsorbed by 5.0×108 spores. Based on
the deduced molecular mass of 17.46 kDa for Bcp1, we estimated that
about 9.5×109 molecules of Bcp1 can be displayed on each spore. The
adsorption is in part due to the presence of the exosporium. Adsorbed
Bcp1 localized in the space between the outer coat and the exosporium
and this unusual localization contributed to the protection of the en-
zyme from degradation by treatment with SIF or SGF.
The Bcp1-spore interaction is highly stable. The enzyme was not
spontaneously released under the reaction conditions and the presence
of high concentrations of other molecules outside the spore did not
displace the adsorbed molecules. However, a partial release of the ad-
sorbed Bcp1 was observed when the pH conditions shifted from acidic
to neutral. All these properties are particularly desirable for an oral
delivery system aimed at crossing the stomach and delivering the
transported molecules at the level of the intestinal mucosal surfaces.
An additional interesting observation highlighted by this report is
that B. megaterium spores have an endogenous antioxidant activity. This
is in part associated with the exosporium and represents a potentially
useful property for a display platform to be used for the delivery of
molecules to animal mucosal surfaces.
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